{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:21:19Z","timestamp":1789057279672,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.obpill.2026.100277","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:37:48Z","timestamp":1779320268000},"page":"100277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Virtual shared medical appointments for obesity and GLP-1 medications: A scalable method for optimizing care delivery"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-7226","authenticated-orcid":false,"given":"Jacob","family":"Mirsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayemi","family":"Olubowale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-4257","authenticated-orcid":false,"given":"Ryan M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.obpill.2026.100277_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jamacardio.2024.4657","article-title":"Semaglutide eligibility across all current indications for US adults","volume":"10","author":"Shi","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.obpill.2026.100277_bib2","series-title":"KFF Health Tracking Poll May 2024: The Public's Use and Views of GLP-1 Drugs","author":"Montero","year":"2024"},{"key":"10.1016\/j.obpill.2026.100277_bib3","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American college of lifestyle medicine, the American society for nutrition, the obesity medicine association, and the obesity society","author":"Mozaffarian","year":"2025","journal-title":"Obesity Pillars"},{"issue":"9","key":"10.1016\/j.obpill.2026.100277_bib4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jamainternmed.2025.1794","article-title":"Integrating diet and physical activity when prescribing GLP-1s\u2014Lifestyle factors remain crucial","volume":"185","author":"Mehrtash","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.obpill.2026.100277_bib5","unstructured":"The White House. Fact Sheet: President Donald j. Trump Announces Major Developments in Bringing Most-Favored-Nation Pricing to American Patients. The White House. Accessed November 26, 2025. https:\/\/www.whitehouse.gov\/fact-sheets\/2025\/11\/fact-sheet-president-donald-j-trump-announces-major-developments-in-bringing-most-favored-nation-pricing-to-american-patients\/."},{"key":"10.1016\/j.obpill.2026.100277_bib6","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fnut.2024.1338727","article-title":"Implementation of a virtual, shared medical appointment program that focuses on food as medicine principles in a population with obesity: the SLIM program","volume":"11","author":"Kirbach","year":"2024","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.obpill.2026.100277_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1056\/NEJMsb2507600","article-title":"Transforming health care \u2014 shared commitments for a learning health system","volume":"393","author":"Madara","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2026.100277_bib8","article-title":"Characterizing primary care patient referrals and attendance patterns for virtual lifestyle medicine shared medical appointments","volume":"53","author":"Popescu","year":"2025","journal-title":"Prev Med Rep"},{"issue":"8","key":"10.1016\/j.obpill.2026.100277_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.obpill.2026.100277_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s13300-023-01382-9","article-title":"Real-world evaluation of GLP-1 receptor agonist therapy persistence, adherence and therapeutic inertia among obese adults with type 2 diabetes","volume":"14","author":"Palanca","year":"2023","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.obpill.2026.100277_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/15598276241274233","article-title":"Patient perspectives on lifestyle medicine virtual group visits","author":"Vigue","year":"2024","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/j.obpill.2026.100277_bib12","article-title":"Delivering lifestyle interventions for chronic disease care sustainably and at scale through virtual group medical visits in primary care","author":"Mirsky","year":"2026","journal-title":"NEJM Catal Innov Care Deliv"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:33:25Z","timestamp":1787988805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":12,"alternative-id":["S2667368126000331"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100277","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual shared medical appointments for obesity and GLP-1 medications: A scalable method for optimizing care delivery","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100277"}}